IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Octagon Capital Advisors LP

Q4 2022 Holdings

Filed 2023-02-14 | 32 holdings | $642.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Apellis Pharmaceuticals Inc(APLS)COM03753U106$163.4M3,160,00025.4%
Chinook Therapeutics Inc(290A)COM16961L106$66.9M2,551,70310.4%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$64.5M2,468,00010.0%
Arcus Biosciences Inc(RCUS)COM03969F109$51.3M2,482,7008.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$34.0M750,0005.3%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$33.9M761,3985.3%
Iveric BIO Inc(OPHTEUR)COM46583P102$27.4M1,278,0004.3%
Viridian Therapeutics Inc(VRDN)COM92790C104$24.1M824,2003.7%
Tandem Diabetes Care Inc(TNDM)COM NEW875372203$21.3M474,9293.3%
Aerovate Therapeutics IncCOM008064107$18.2M621,7122.8%
Spdr SER TR(XBI)S&P BIOTECH78464A870$16.6M199,4172.6%
Vera Therapeutics Inc(VERA)CL A92337R101$12.9M665,1562.0%
Intra-Cellular Therapies Inc(ITCIEUR)COM46116X101$11.7M220,9531.8%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$11.7M1,859,2001.8%
4D Molecular Therapeutics in(FDMT)COM35104E100$11.1M499,9961.7%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$9.0M1,225,0001.4%
Iteos Therapeutics Inc(5E7)COM46565G104$8.7M445,0001.4%
Viking Therapeutics Inc(VKTX)COM92686J106$8.2M870,5001.3%
Avidity Biosciences Inc(RNA)COM05370A108$7.2M324,6291.1%
Bridgebio Pharma Inc(BBIO)COM10806X102$7.1M933,7431.1%
Stoke Therapeutics Inc(STOK)COM86150R107$7.0M763,4561.1%
Xilio Therapeutics Inc(XLO)COM98422T100$6.5M2,425,0001.0%
89Bio Inc(ETNBGBP)COM282559103$4.8M380,0000.8%
Gossamer BIO Inc(GOSS)COM38341P102$4.2M1,958,0690.7%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$2.0M100,0000.3%
Praxis Precision Medicines ICOM74006W108$1.9M800,0000.3%
Dexcom Inc(DXCM)COM252131107$1.7M15,0000.3%
Prometheus Biosciences IncCOM74349U108$1.7M15,0000.3%
Jounce Therapeutics Inc(JNCEEUR)COM481116101$1.6M1,400,0000.2%
Mereo Biopharma Group PLC(MREO)SPON ADS589492107$750.0K1,000,0000.1%
Nuvalent Inc(NUVL)COM670703107$744.5K25,0000.1%
Century Therapeutics Inc(IPSC)COM15673T100$230.9K45,0000.0%